Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26FCY6U
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $55,774
Award facts
- Contract value 100% obligated
- $55,774.27 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $55,774.27 delivery order to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300mg dose in pen format on January 8, 2026, with completion targeted for January 9, 2026. This is a firm fixed-price, non-set-aside contract with performance to be executed from the company's Conshohocken, Pennsylvania location. The order represents a task under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999 global pharmaceutical supply vehicle designated SPE2DX that extends through December 2026. This parent IDC enables the company to provide comprehensive pharmaceutical support including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to military healthcare systems worldwide.
AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal agencies on a fully competitive basis. The company's substantial presence in federal medical procurement—demonstrated through its significant IDC with DLA and regular delivery orders for critical medications—positions it as a key supplier for Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Cosentyx is a specialty biologic medication used for autoimmune conditions, reflecting the immunosuppressive pharmaceutical needs of military and veteran healthcare programs supported through DLA's medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FCY6U?
SPE2DR26FCY6U was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26FCY6U worth?
The government has obligated $55,774 on SPE2DR26FCY6U.
Is contract SPE2DR26FCY6U an order under another contract?
Yes. SPE2DR26FCY6U is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCY6U competed?
The extent of competition for SPE2DR26FCY6U was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award